By Tom Winnifrith | Tuesday 8 May 2018
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Chaired by Adam Reynolds this session boated the CEOS of Immupharma, Optibiotix, soon to IPO Phynova and ValiRx. Enjoy.
The 2019 UK Investor Show is on 30 March. Already more than one quarter of the 135 PLC stands are booked out while the big name speakers including Vin Murria, Nigel Wray, Mark Slater, Nick Leslau and myself and Malcolm Stacey are booked in to re-appear. Put the date in your diary and book your seats now HERE - use the promotional code EARLYBIRD19 to get a 50% discount on both investor class and gold tickets - offer ends July 1.
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen